跳至主要内容
临床试验/CTRI/2021/06/034224
CTRI/2021/06/034224尚未招募未知

Study of Serum Calcitonin Gene Related Peptide (CGRP) in Migraine and its Correlation with Symptom Severity. - MICCO

Dr Hafeeza Sultana0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1) Patients who are above 18 years and below 50 years of age, patients who are mobile, and patients who are consenting to participate in the study.
  • 2) Patients with denovo (newly diagnosed) with Migraine and presenting with headache.

排除标准

  • 1)Patients who are below 18 years and above 50 years of age, patients who are mobile, and patients who are consenting to participate in the study.
  • 2)Patients who have conditions or co-morbidities like Myocardial Infarction, cardiac failure, Resistant Hypertension, Chronic Kidney Disease, Acute Kidney Failure- On Hemodialysis, Sepsis, and Temporomandibular Joint disorders because these conditions increase serum CGRP levels.
  • 3)Patients having conditions which mimic Migraine like Intracranial Aneurysms, Space Occupying Lesion, Pituitary Adenomas, Exertional Headache, Crash Migraine and Cerebral Venous Thrombosis.
  • 4)Pregnant or postmenopausal women were not included in the study as research has suggested that these conditions effect serum CGRP levels.

研究者

发起方
Dr Hafeeza Sultana

相似试验